Back
Scholar Rock Holding Vs. NeuroBo Pharmaceuticals Industry Stock Comparison
Buy
84
SRRK
Scholar Rock Holding
Last Price:
27.00
Seasonality Move:
15.59%
Sell
20
NRBO
NeuroBo Pharmaceuticals
Last Price:
2.34
Seasonality Move:
-8.74%
Buy
84
Scholar Rock Holding (SRRK)
is a Buy
Is Scholar Rock Holding a Buy, Sell or Hold?
- The current Scholar Rock Holding [SRRK] share price is $27.50. The Score for SRRK is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
- SRRK is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
20
NeuroBo Pharmaceuticals (NRBO)
is a Sell
Is NeuroBo Pharmaceuticals a Buy, Sell or Hold?
- The current NeuroBo Pharmaceuticals [NRBO] share price is $2.39. The Score for NRBO is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- NRBO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
SRRK Stock Price Chart
What is Scholar Rock Holding's stock price today?
-
The Scholar Rock Holding share price today is $27.50
The current trend is moderately bearish and SRRK is experiencing slight selling pressure.
NRBO Stock Price Chart
What is NeuroBo Pharmaceuticals's stock price today?
-
The NeuroBo Pharmaceuticals share price today is $2.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRBO is experiencing selling pressure, which indicates risk of future bearish movement.
SRRK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.81 | Buy |
| Relative Strength Index (14 RSI): | 54.84 | Buy |
| Chaikin Money Flow: | -79112 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.44 - 29.92) | Sell |
| Bollinger Bands (100): | (5.19 - 23.45) | Buy |
NRBO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 36.5 | Sell |
| Chaikin Money Flow: | -55184 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.52 - 2.86) | Sell |
| Bollinger Bands (100): | (2.82 - 4.26) | Sell |
SRRK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.25 | Sell |
| 20-day SMA: | 28.91 | Sell |
| 50-day SMA: | 19.82 | Buy |
| 200-day SMA: | 14.07 | Buy |
| 8-day EMA: | 27.97 | Sell |
| 20-day EMA: | 27.26 | Buy |
| 50-day EMA: | 22.19 | Buy |
| 200-day EMA: | 15 | Buy |
NRBO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.62 | Sell |
| 20-day SMA: | 2.71 | Sell |
| 50-day SMA: | 2.97 | Sell |
| 200-day SMA: | 3.92 | Sell |
| 8-day EMA: | 2.59 | Sell |
| 20-day EMA: | 2.68 | Sell |
| 50-day EMA: | 2.95 | Sell |
| 200-day EMA: | 4.84 | Sell |
Scholar Rock Holding Earnings Growth & SRRK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.60 per share, and a decrease next year of $0.07 per share.
NeuroBo Pharmaceuticals Earnings Growth & NRBO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Scholar Rock Holding Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NeuroBo Pharmaceuticals Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||